Deep Longevity Company
Deep Longevity is a biotechnology company transforming longevity R&D through AI-discovered biomarkers of aging.
Investors
Funding Status:
M&A
Headquarters:
Hong Kong, Hong Kong Island, Hong Kong
Founded Date:
2020-01-01
Employee Number:
1-10
Last Funding Type:
Series A
Estimated Revenue:
$1M to $10M
Industry:
Biomarkers for Personalized Medicine
Investors Number:
7
Technology:
Physiological Biomarkers
Investor Type:
For Profit
Last Funding Date:
2020-07-14
Number Of Exists:
1-10